FDA Drug Safety Initiative Will Include New Website On Rx Risks
This article was originally published in The Pink Sheet Daily
Executive Summary
The site is intended as an avenue for the agency to disclose safety issues that have not yet been definitively reviewed, and to emphasize the risks with all prescription drugs. The website proposal is understood to be in the internal agency review phase.